PARIS–( COMPANY CORD)– BrightHeart, a leading AI pioneer in obstetric and pediatric cardiology modern technology, reveals it has actually obtained FDA 510( k) clearance for its initial expert system software application, developed to change prenatal ultrasound assessments of the fetal heart. This landmark notes a substantial advancement in among one of the most difficult and essential locations of prenatal treatment. Fetal heart ultrasounds tests are important for identifying genetic heart flaws (CHDs), which are the
发布者：Dr.Durant，转转请注明出处：https://robotalks.cn/brightheart-secures-fda-clearance-for-first-ai-software-revolutionizing-prenatal-fetal-heart-ultrasound-evaluations/
